Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lipocine Inc. (LPCN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0100-0.0400 (-3.81%)
At close: 04:00PM EST
1.0100 0.00 (0.00%)
After hours: 06:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Continuation Diamond (Bearish)

Continuation Diamond (Bearish)

Previous Close1.0500
Open1.0600
Bid1.0100 x 3200
Ask1.0200 x 3100
Day's Range0.9678 - 1.0698
52 Week Range0.9678 - 2.4200
Volume600,042
Avg. Volume646,482
Market Cap89.174M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2180
Earnings DateNov 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LPCN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lipocine Inc.
    ENDP: What does Argus have to say about ENDP?ENDO INTERNATIONAL PLC has an Investment Rating of SELL; a target price of $5.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • Benzinga

    5 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Castlight Health The Trade: Castlight Health, Inc. (NYSE: CSLT) CEO Maeve Omeara acquired a total of 186290 shares . The i

  • Zacks Small Cap Research

    LPCN: Third Quarter Update

    By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 10, 2021 Lipocine (NASDAQ:LPCN) filed its Form 10-Q and posted its earnings release for the three month period ending September 30, 2021. Highlights for the third quarter 2021 and to-date include: ➢ Settlement with Clarus Therapeutics - July 2021 ➢ LPCN 1144

  • PR Newswire

    Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021

    Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the third quarter and nine months ended September 30, 2021, and provided a corporate update.

Advertisement
Advertisement